Related Experiment Video
Updated: Jun 28, 2026
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Multiple sclerosis
Alastair Compston1, Alasdair Coles
1Department of Clinical Neurosciences, University of Cambridge Clinical School, Addenbrooke's Hospital, Cambridge, UK.
Abstract:
Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually recover. However, over time the pathological changes become dominated by widespread microglial activation associated with extensive and chronic neurodegeneration, the clinical correlate of which is progressive accumulation of disability. Paraclinical investigations show abnormalities that indicate the distribution of inflammatory lesions and axonal loss (MRI); interference of conduction in previously myelinated pathways (evoked electrophysiological potentials); and intrathecal synthesis of oligoclonal antibody (examination by lumbar puncture of the cerebrospinal fluid). Multiple sclerosis is triggered by environmental factors in individuals with complex genetic-risk profiles. Licensed disease modifying agents reduce the frequency of new episodes but do not reverse fixed deficits and have questionable effects on the long-term accumulation of disability and disease progression. We anticipate that future studies in multiple sclerosis will provide a new taxonomy on the basis of mechanisms rather than clinical empiricism, and so inform strategies for improved treatment at all stages of the disease.
Insights
Multiple sclerosis involves inflammation and neurodegeneration in the central nervous system. Current treatments manage relapses but not long-term disability progression, necessitating new therapeutic strategies.
Area of Science:
- Neuroscience
- Immunology
- Neurology
Background:
- Multiple sclerosis (MS) is an inflammatory central nervous system disorder characterized by demyelination and axonal damage.
- Early MS involves transient inflammation and incomplete remyelination, leading to relapsing-remitting neurological dysfunction.
- Chronic MS progresses due to microglial activation and neurodegeneration, causing irreversible disability accumulation.
Purpose of the Study:
- To review the pathological mechanisms and clinical progression of multiple sclerosis.
- To evaluate the efficacy of current disease-modifying agents.
- To highlight the need for mechanism-based therapeutic strategies in MS.
Main Methods:
- Review of existing literature on multiple sclerosis pathophysiology and treatment.
- Analysis of paraclinical findings including MRI, evoked potentials, and cerebrospinal fluid analysis.
- Discussion of genetic and environmental factors contributing to MS.
Main Results:
- MS pathology transitions from transient inflammation to chronic neurodegeneration.
- Paraclinical investigations reveal inflammatory lesions, axonal loss, and intrathecal antibody synthesis.
- Current disease-modifying agents primarily reduce relapse frequency, with limited impact on fixed deficits or long-term progression.
Conclusions:
- Future multiple sclerosis research should focus on a mechanism-based taxonomy for improved treatment.
- Novel therapies are needed to address neurodegeneration and disability accumulation in all stages of MS.
- Understanding the complex interplay of genetic and environmental factors is crucial for developing effective MS interventions.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
01:22Myasthenia Gravis ll: Pathophysiology
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...